FTC sues to block Amgen’s acquisition of Horizon Therapeutics
May 16, 2023 at 13:44 PM EDT
Deal could allow Amgen to "entrench the monopoly positions" of two Horizon medications, regulators say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|